By The Online Investor Staff, updated Tue., Nov. 24, 5:05 PM
Slide #1. Kitov Pharmaceuticals Holdings Ltd. — Initial Public Offering
||Kitov Pharmaceuticals Holdings Ltd.
|Price Per Share:
||Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV), a biopharmaceutical company focused on the development of therapeutic candidates for the simultaneous treatment of various clinical conditions, today announced the pricing of its initial public offering in the United States of 3,158,900 American Depository Shares ("ADSs") and warrants to purchase up to 3,158,900 ADSs. Each ADS, representing 20 ordinary shares of the Company, and each warrant to purchase one ADS, are offered at a combined price to the public of $4.13. The warrants will have a per ADS exercise price of $4.13, are exercisable immediately, and will have a term of five years. The gross proceeds to Kitov from this offering are expected to be $13,046,257, prior to deducting underwriting discounts, commissions and other estimated offering expenses. Kitov has granted the underwriters a 45-day option to purchase up to an additional 473,835 ADSs and/or warrants to purchase 473,835 ADSs to cover over-allotments, if any.
IPOs: Kitov Pharmaceuticals Holdings Ltd.
List of IPOs in this Slideshow:
Company Ticker IPO Date
Multi Packaging Solutions International LimitedMPSX
Adesto Technologies Corporation IOTS
MyoKardia, Inc. MYOK
Equity Bancshares, Inc. EQBK
Premier, Inc. PINC
WAVE Life Sciences Ltd. WVE
Noble Midstream Partners LP NBLX
Xtera Communications, Inc. XCOM
Mesoblast Limited MESO
Mimecast Limited MIME
Match Group, Inc. MTCH
Square, Inc. SQ
Duluth Holdings Inc. DLTH
Kitov Pharmaceuticals Holdings Ltd. KTOV
November 24, 2015 5:05 PM Eastern